Funke-Chambour, M., Albera, C.
, Bendstrup, E., Costabel, U., Grutters, J. C., Harari, S., Johannson, K. A., Kreuter, M., Strambu, I., Vancheri, C., Varone, F., Vitulo, P., Wuyts, W. A., Martinez, F. & Raghu, G. (2021).
Suggestions for improving clinical utility of future guidelines for diagnosis and management of idiopathic pulmonary fibrosis: Results of a Delphi survey.
European Respiratory Journal,
57(4), Article 2004219.
https://doi.org/10.1183/13993003.04219-2020
Glaspole, I., Bonella, F., Bargagli, E., Glassberg, M. K., Caro, F., Stansen, W., Quaresma, M., Orsatti, L.
& Bendstrup, E. (2021).
Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities.
Respiratory Research,
22(1), Article 125.
https://doi.org/10.1186/s12931-021-01695-y
Gouliaev, A., Hilberg, O.
, Christensen, N. L., Rasmussen, T., Ibsen, R. & Løkke, A. (2021).
Comorbidity among Danish lung cancer patients before and after initial cancer diagnosis.
European Clinical Respiratory Journal,
8(1), Article 1861579.
https://doi.org/10.1080/20018525.2020.1861579
Gouliaev, A., Risikesan, J., Christensen, N. L., Rasmussen, T. R., Hilberg, O., Ibsen, R. & Løkke, A. (2021).
Direct and indirect economic burden of lung cancer in Denmark a nationwide study.
European Clinical Respiratory Journal,
8(1), Article 1951963.
https://doi.org/10.1080/20018525.2021.1951963
Hansen, S., Hilberg, O., Ulrik, C. S., Bodtger, U., M. Rasmussen, L., D. Assing, K., Wimmer-Aune, A., B. Rasmussen, K., Bjerring, N., Christiansen, A.
, Schmid, J., Krogh, N. S. & Porsbjerg, C. (2021).
The Danish severe asthma register: an electronic platform for severe asthma management and research.
European Clinical Respiratory Journal,
8(1), Article 1842117.
https://doi.org/10.1080/20018525.2020.1842117
Hedgeman, E.
, Nørgaard, M., Dalvi, T.
, Pedersen, L., Hansen, H. P., Walker, J., Midha, A., Shire, N., Boothman, A. M., Fryzek, J. P., Rigas, J., Mellemgaard, A.
, Rasmussen, T. R., Hamilton-Dutoit, S. & Cronin-Fenton, D. (2021).
Programmed cell death ligand-1 expression and survival in a cohort of patients with non-small cell lung cancer receiving first-line through third-line therapy in Denmark.
Cancer epidemiology,
73, Article 101976.
https://doi.org/10.1016/j.canep.2021.101976
Hoffmann-Vold, A. M.
, Bendstrup, E., Dimitroulas, T., Hesselstrand, R., Morais, A., Peltomaa, R., Smith, V., Welling, J., Vonk, M. C. & Wuyts, W. A. (2021).
Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews.
Rheumatology (United Kingdom),
60(12), 5601-5609.
https://doi.org/10.1093/rheumatology/keab154
Hoyer, N., Jessen, H.
, Prior, T. S., Sand, J. M. B., Leeming, D. J., Karsdal, M. A., Åttingsberg, E. K. A., Vangsgaard, G. K. M.
, Bendstrup, E. & Shaker, S. B. (2021).
High turnover of types III and VI collagen in progressive idiopathic pulmonary fibrosis.
Respirology,
26(6), 582-589.
https://doi.org/10.1111/resp.14056
Hyldgaard, C., Bendstrup, E., Pedersen, A. B., Pedersen, L. & Ellingsen, T. (2021).
Interstitial lung disease in connective tissue diseases: Survival patterns in a population-based cohort.
Journal of Clinical Medicine,
10(21), Article 4830.
https://doi.org/10.3390/jcm10214830
Jessen, H., Hoyer, N.
, Prior, T. S., Frederiksen, P., Rønnow, S. R., Karsdal, M. A., Leeming, D. J.
, Bendstrup, E., Sand, J. M. B. & Shaker, S. B. (2021).
Longitudinal serological assessment of type VI collagen turnover is related to progression in a real-world cohort of idiopathic pulmonary fibrosis.
BMC Pulmonary Medicine,
21, Article 382.
https://doi.org/10.1186/s12890-021-01684-3
Jessen, H., Hoyer, N.
, Prior, T. S., Frederiksen, P., Karsdal, M. A., Leeming, D. J.
, Bendstrup, E., Sand, J. M. B. & Shaker, S. B. (2021).
Turnover of type I and III collagen predicts progression of idiopathic pulmonary fibrosis.
Respiratory Research,
22(1), Article 205.
https://doi.org/10.1186/s12931-021-01801-0
Kalluri, M., Luppi, F., Vancheri, A., Vancheri, C., Balestro, E., Varone, F., Mogulkoc, N., Cacopardo, G., Bargagli, E., Renzoni, E., Torrisi, S., Calvello, M., Libra, A., Pavone, M., Bonella, F., Cottin, V., Valenzuela, C., Wijsenbeek, M.
& Bendstrup, E. (2021).
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: Where to go from here? European Respiratory Review,
30(160), Article 210026.
https://doi.org/10.1183/16000617.0026-2021
Kølner-Augustson, L., Prior, T. S., Skivild, V., Aalestrup, A.
& Bendstrup, E. (2021).
Fatigue in idiopathic pulmonary fibrosis measured by the Fatigue Assessment Scale during antifibrotic treatment.
European Clinical Respiratory Journal,
8(1), Article 1853658.
https://doi.org/10.1080/20018525.2020.1853658
Kronborg-White, S., Sritharan, S. S., Madsen, L. B., Folkersen, B., Voldby, N.
, Poletti, V., Rasmussen, T. R. & Bendstrup, E. (2021).
Integration of cryobiopsies for interstitial lung disease diagnosis is a valid and safe diagnostic strategy-experiences based on 250 biopsy procedures.
Journal of Thoracic Disease,
13(3), 1455-1465.
https://doi.org/10.21037/jtd-20-2431
Lamb, D., De Sousa, D., Quast, K., Fundel-Clemens, K., Erjefält, J. S., Sandén, C.
, Hoffmann, H. J., Kästle, M., Schmid, R., Menden, K. & Delic, D. (2021).
RORγt inhibitors block both IL-17 and IL-22 conferring a potential advantage over anti-IL-17 alone to treat severe asthma.
Respiratory Research,
22, Article 158.
https://doi.org/10.1186/s12931-021-01743-7